The Patent Finder

Global Life Sciences Solutions Operations UK Ltd.

124 patents currently held · Updated Nov 16, 2026
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
17
Ending by 2030
May 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 4 fees due Dec 2 to 23, 2026 · next Dec 2
  • 5 fees due Jan 2 to 30, 2027 · next Jan 2
  • 2 fees due Feb 6 to 27, 2027 · next Feb 6
  • 1 fee due Mar 12, 2027
    The maintenance fee for Porous membranes with a polymer grafting, methods and uses thereof (US 11,754,563) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
  • 4 fees due Apr 13 to 27, 2027 · next Apr 13
  • 1 fee due May 12, 2027
    The maintenance fee for Method, substrate and device for separating nucleic acids (US 10,472,620) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
  • 3 fees due Jun 10 to 30, 2027 · next Jun 10
  • 2 fees due Aug 9 to 16, 2027 · next Aug 9
  • 6 fees due Sep 1 to 24, 2027 · next Sep 1
  • 1 fee due Oct 21, 2027
    The maintenance fee for Substrates and methods for collection, stabilization and elution of biomolecules (US 10,625,242) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
  • 2 fees due Nov 3 to 10, 2027 · next Nov 3

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,951,379Isothermal DNA amplification
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,100,292Mutant Endonuclease V Enzymes and Applications Thereof
In force
 · Low confidence
In forceLow confidence
US 7,790,410Method and apparatus for determining hemocompatibility
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,506,847Method and system for selective isolation of target biological molecules in a general purpose system
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,041,090Method of, and apparatus and computer software for, performing image processing
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,361,712Contamination-free reagents for nucleic acid amplification
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,131,052Method of processing an image
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,268,116Endonuclase-assisted isothermal amplification using contamination-free reagents
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,202,972Isothermal DNA amplification
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,254,484Methods and systems for processing samples on porous substrates
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 124 patents shown.
Pro members see all 124.
Pro members: see all 124 patents
Also on record, not counted in the 124: 4 patents in force now held by others · 10 lapsed for an unpaid fee · 9 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 2 abandoned

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited